Performance of LEGN Legend Biotech Corp | -23.6% in 12m
Compare LEGN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Legend Biotech Corp with its related Sector/Index XBI
Performance Duell LEGN vs XBI
| TimeFrame | LEGN | XBI |
|---|---|---|
| 1 Week | -6.16% | 1.00% |
| 1 Month | -9.83% | 3.39% |
| 3 Months | 10.9% | 5.72% |
| 6 Months | -22.1% | 3.10% |
| 12 Months | -23.6% | 28.65% |
| YTD | -14.2% | 9.92% |
| Rel. Perf. 1m | -1.42 | |
| Rel. Perf. 3m | -0.31 | |
| Rel. Perf. 6m | -2.88 | |
| Rel. Perf. 12m | -2.88 | |
| Spearman 1m | -0.53 | -0.17 |
| Spearman 3m | 0.53 | 0.62 |
Is Legend Biotech Corp a good stock to buy?
No, based on ValueRay Fundamental Analyses, Legend Biotech Corp (NASDAQ:LEGN) is currently (September 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -53.30 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LEGN as of September 2024 is 53.80. This means that LEGN is currently overvalued and has a potential downside of 6.94% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LEGN as of September 2024 is 53.80. This means that LEGN is currently overvalued and has a potential downside of 6.94% (Sold with Premium).
Is LEGN a buy, sell or hold?
- Strong Buy: 9
- Buy: 10
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: LEGN is performing better - Values below 0%: LEGN is underperforming
Compare LEGN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.88% | -14.67% | -30.99% | -50.97% |
| US NASDAQ 100 | QQQ | -8.80% | -14.67% | -29.09% | -52.06% |
| US Dow Jones Industrial 30 | DIA | -7.02% | -14.54% | -28.38% | -44.36% |
| German DAX 40 | DBXD | -5.79% | -14.29% | -24.82% | -41.83% |
| UK FTSE 100 | ISFU | -5.37% | -12.99% | -32.99% | -41.19% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.32% | -5.32% | -13.42% | -12.02% |
| Hongkong Hang Seng | HSI | -5.72% | -13.01% | -18.99% | -18.64% |
| Japan Nikkei 225 | EXX7 | -7.31% | -15.80% | -18.95% | -37.34% |
| India NIFTY 50 | INDA | -7.07% | -13.58% | -33.86% | -51.57% |
| Brasil Bovespa | EWZ | -3.92% | -9.32% | -15.04% | -20.64% |
LEGN Legend Biotech Corp vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.72% | -11.51% | -30.06% | -52.33% |
| Consumer Discretionary | XLY | -8.32% | -19.93% | -27.99% | -35.73% |
| Consumer Staples | XLP | -6.38% | -15.66% | -33.48% | -42.65% |
| Energy | XLE | -3.88% | -4.55% | -19.36% | -19.16% |
| Financial | XLF | -4.89% | -15.05% | -31.57% | -53.17% |
| Health Care | XLV | -7.04% | -14.13% | -28.91% | -43.36% |
| Industrial | XLI | -7.80% | -14.37% | -28.58% | -48.66% |
| Materials | XLB | -7.06% | -14.02% | -24.64% | -38.27% |
| Real Estate | XLRE | -9.05% | -17.84% | -36.63% | -49.97% |
| Technology | XLK | -10.93% | -15.63% | -26.42% | -54.43% |
| Utilities | XLU | -7.22% | -14.86% | -46.18% | -46.91% |
| Aerospace & Defense | XAR | -7.27% | -13.65% | -32.16% | -54.92% |
| Biotech | XBI | -7.16% | -13.22% | -25.22% | -52.21% |
| Homebuilder | XHB | -9.37% | -17.82% | -32.35% | -71.31% |
| Retail | XRT | -5.66% | -10.75% | -20.13% | -43.21% |
Does Legend Biotech Corp outperform its market, is LEGN a Sector Leader?
No, over the last 12 months Legend Biotech Corp (LEGN) made -23.56%, while its related Sector, the SPDR S&P Biotech (XBI) made 28.65%.
Over the last 3 months LEGN made 10.86%, while XBI made 5.72%.
No, over the last 12 months Legend Biotech Corp (LEGN) made -23.56%, while its related Sector, the SPDR S&P Biotech (XBI) made 28.65%.
Over the last 3 months LEGN made 10.86%, while XBI made 5.72%.
| Period | LEGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -9.83% | 3.39% | 4.84% |
| 3 Months | 10.86% | 5.72% | 3.61% |
| 12 Months | -23.56% | 28.65% | 27.41% |